Eye diseases
Showing 1 - 25 of >10,000
Multimodal Machine Learning for Auxiliary Diagnosis of Eye
Not yet recruiting
- Eye Diseases
- Multimodal Machine Learning Program for Auxiliary Diagnosis of Eye Diseases
-
Nanjing, China
- +2 more
Jun 26, 2023
Eye Diseases Trial in Guangzhou
Recruiting
- Eye Diseases
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center, Sun Yat-sen University
Apr 29, 2023
es to Capture the Real Life of Children With Rare Eye Diseases
Not yet recruiting
- Eye Diseases
- +3 more
- Mixed Methods Research (MMR) using quantitative (QUAN) and qualitative (QUAL) tools
-
Strasbourg, FranceCentre de Référence pour les Affections Rares en Génétique Ophta
Oct 3, 2023
Eye Diseases Trial in Amsterdam (Eye screening)
Recruiting
- Eye Diseases
- Eye screening
-
Amsterdam, NetherlandsAmsterdam UMC
Sep 21, 2023
Development of an IT Tool Able to Identify Ocular Conditions
Withdrawn
- Eye Diseases
- Measurement of corneal biomechanical properties
- (no location specified)
Aug 1, 2023
Vascular Pathology in Eye Diseases Using Using Optical Coherence
Completed
- Retinal Disease
- optical coherence tomography angiography
-
Bern, SwitzerlandInselspital Bern, Department of Ophthalmology
Nov 28, 2022
Dry Eye Disease Trial in Hanzhou (Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome (PSC-MSC-Exo) Eye Drops)
Not yet recruiting
- Dry Eye Disease
- Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome (PSC-MSC-Exo) Eye Drops
-
Hanzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Feb 21, 2023
Cell Collection to Study Eye Diseases
Recruiting
- Retinal Disease
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Mitochondrial DNA in Vitreous Fluid and Blood in Eye Disease or
Withdrawn
- Eye Diseases
- +5 more
- Sample collection from tissue discard
- (no location specified)
Jan 30, 2023
Dry Eye Trial in Gallarate (Rexon-Eye)
Completed
- Dry Eye
- Rexon-Eye
-
Gallarate, VA, ItalyCentro Oculistico Borroni
Nov 3, 2023
Eyelid Diseases, Eyelid Movement Disorders, Dry Eye Trial in New York (TriLift device)
Not yet recruiting
- Eyelid Diseases
- +4 more
- TriLift device
-
New York, New YorkManhattan Face and Eye Cosmetic and Orbital Surgery
Jul 11, 2023
Eye Disease Trial in Coimbra
Active, not recruiting
- Eye Disease
-
Coimbra, PortugalCEC
Jan 12, 2023
Dry Eye Disease Trial in Tehran (Eye mask)
Not yet recruiting
- Dry Eye Disease
- Eye mask
-
Tehran, Iran, Islamic Republic ofHamideh Sabbaghi
Aug 24, 2023
BCC Excision Revisited
Completed
- Basal Cell Carcinoma
- +2 more
- Surgery
-
Vienna, AustriaMedical University of Vienna
May 14, 2023
Riboflavin-Enhanced Hyaluronic Acid Eye Drops in Treating Dry
Completed
- Dry Eye Disease
- modified hyaluronic acid 0.1% covalently linked to Riboflavin
- hyaluronic acid 0.1%
-
NAples, ItalyUniversity of Naples Federico II
Nov 2, 2023
Artificial Intelligent System for Eye Emergency Triage and
Recruiting
- Emergencies
- Eye Diseases
- Artificial intelligent system for eye emergency triage and primary diagnosis
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center, Sun Yat-sen Univerisity
Dec 25, 2022
Cataract; Eye Disease Trial in Augusta (Novel "Snaps" Eye Shield, Standard Alcon Eye Shield)
Recruiting
- Cataract; Eye Disease
- Novel "Snaps" Eye Shield
- Standard Alcon Eye Shield
-
Augusta, GeorgiaAugusta University
Jul 14, 2023
Swept Source OCT Imaging With the DREAM VG-OCT
Not yet recruiting
- Eye Diseases
- +2 more
- DREAM OCT
-
Palo Alto, CaliforniaByers Eye Institute
May 17, 2023
Eye Diseases Trial in Saint-Étienne (Retro-illuminator)
Recruiting
- Eye Diseases
- Retro-illuminator
-
Saint-Étienne, FranceCHU Saint-Etienne
Feb 8, 2023
Dry Eye Syndromes, Eye Diseases Trial in Memphis (OTX-DED, Controlled Insertion, Collagen Punctal Plug)
Not yet recruiting
- Dry Eye Syndromes
- Eye Diseases
- OTX-DED
- +2 more
-
Memphis, TennesseeOcular Therapeutix
Apr 12, 2023
Eye Diseases Trial in Damieta (Transcutaneous levator recession)
Completed
- Eye Diseases
- Transcutaneous levator recession
-
Damieta, New Damietta, EgyptEhab tharwat
Jan 1, 2023